WeVote
Log In

Bill

Bill

HB 1818

Relating to examinations of health maintenance organizations and insurers by the commissioner of insurance regarding compliance with certain utilization review and preauthorization requirements; authorizing a fee.

89th Legislature (2025) Introduced by Hubert Vo

Authorizes Texas insurance commissioner to examine HMOs and insurers for preauthorization compliance violations and assess fees to fund regulatory oversight.

Left pending in committee
#healthmaintenanceorganizations(s0853) #insurance #commissionerof(v0396) #insurance--health&accident(i0422)
0
WeVote Research Nonpartisan
Bill Summary · HB 1818

Legislative bill overview

HB 1818 authorizes the Texas Commissioner of Insurance to examine health maintenance organizations (HMOs) and insurers for compliance with utilization review and preauthorization requirements, and establishes a fee mechanism to fund these examinations. The bill creates a regulatory framework for assessing whether insurers are following proper procedures when approving or denying medical treatments.

Why is this important

Utilization review and preauthorization processes directly affect patients' ability to access timely medical care—delays in approval can postpone necessary treatments. This bill provides regulatory oversight tools to ensure insurers aren't improperly denying coverage or creating unnecessary barriers, while the fee structure ensures examinations are funded without general taxpayer burden. Effective enforcement protects consumers from coverage denials while maintaining the insurance market's operational integrity.

Potential points of contention

  • Fee burden on insurers: The authorization fee may increase operational costs for HMOs and insurers, potentially leading to higher premiums passed to consumers
  • Regulatory scope ambiguity: The bill's language regarding "certain utilization review and preauthorization requirements" lacks specificity about which requirements qualify for examination, creating potential implementation uncertainty
  • Enforcement mechanisms unclear: The bill doesn't specify penalties for non-compliance or what remedies patients can pursue if violations are found, potentially limiting practical effectiveness

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.